Form 4: Calidi Biotherapeutics Director Alan R. Stewart Acquires Stock Options
SEC Form 4
Director Alan R. Stewart acquired non-qualified stock options for 20,217 shares of Calidi Biotherapeutics common stock.
Summary
- On October 15, 2024, Alan R. Stewart, a director of Calidi Biotherapeutics, Inc., filed a Form 4.
- The form reports the acquisition of non-qualified stock options to purchase 20,217 shares of common stock.
- These options were granted on September 20, 2024, with an exercise price of $1.09 per share.
- The options vest in monthly installments over one year, starting from the grant date.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard stock option grant. It indicates confidence but doesn't provide substantial new information.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Stock options are a common form of executive compensation in the biotechnology industry, aligning the interests of management with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 09/20/2024 | Grant date of the non-qualified stock options. |
| 10/11/2024 | Date of the transaction (issuance of stock options). |
| 10/15/2024 | Date the Form 4 was filed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.